OSB Participant List by Research Area
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Security Master Symbol Description a AGILENT TECHNOLOGIES INC AA
*The information contained herein is believed to Security Master be reliable but is neither guaranteed by EQIS Capital Management, Inc. its principles nor any affiliated EQIS companies. This information is Symbol Description intended for the exclusive use of investment Adviser Representative. This list is subject to A AGILENT TECHNOLOGIES INC change. AA ALCOA CORP COM Advisor Services are offered through EQIS AAAAX DEUTSCHE ALTERNATIVE ASSET ALLOCATION FU Capital Management, Inc. an SEC Registered AAAP ADVANCED ACCELERATOR APPLIC SPONSORED AD Investment Adviser. For information purposes AAASX DEUTSCHE ALTERNATIVE ASSET ALLOCATION F only, not for public distribution. AABPX AMERICAN BEACON BALANCED INVESTOR AAC AAC HLDGS INC COM AACFX AIM CHINA A AADAX AIM GROWTH ALLOCATION CLASS A AADEX AMERICAN BEACON LARGE CAP VALUE INSTL AADR ADVISORSHARES WCM/BNY MLNFCSD GR ADR ETF AAGIY AIA GROUP LTD SPONS ADR AAGPX AMERICAN BEACON LARGE CAP VALUE INVESTOR AAIFX CROW POINT ALTERNATIVE INCOME FUND AAIPX AMERICAN BEACON INTERNATIONAL EQUITY INV AAL AMERICAN AIRLS GROUP INC COM AAMC ALTISOURCE ASSET MGMT CORP COM AAME ATLANTIC AMERN CORP AAN AARONS, INC. CL A AAOI APPLIED OPTOELECTRONICS INC COM AAON AAON INC PAR $0.004 AAP ADVANCED AUTO PARTS INC AAPC ATLANTIC ALLIANCE PARTNER CORP SHS AAPL APPLE INC COM AAT AMERICAN ASSETS TR INC COM AAU ALMADEN MINERALS LTD AAV ADVANTAGE OIL & GAS LTD AAWW ATLAS AIR WORLDWIDE HLDGS INC COM NEW AAXJ ISHARES MSCI ALL COUNTRY ASIA EX JAPAN I AB ALLIANCEBERNSTEIN HOLDING LP UNIT LTD PA ABAC AOXIN TIANLI GROUP INC NEW -
OSB Representative Participant List by Industry
OSB Representative Participant List by Industry Aerospace • KAWASAKI • VOLVO • CATERPILLAR • ADVANCED COATING • KEDDEG COMPANY • XI'AN AIRCRAFT INDUSTRY • CHINA FAW GROUP TECHNOLOGIES GROUP • KOREAN AIRLINES • CHINA INTERNATIONAL Agriculture • AIRBUS MARINE CONTAINERS • L3 COMMUNICATIONS • AIRCELLE • AGRICOLA FORNACE • CHRYSLER • LOCKHEED MARTIN • ALLIANT TECHSYSTEMS • CARGILL • COMMERCIAL VEHICLE • M7 AEROSPACE GROUP • AVICHINA • E. RITTER & COMPANY • • MESSIER-BUGATTI- CONTINENTAL AIRLINES • BAE SYSTEMS • EXOPLAST DOWTY • CONTINENTAL • BE AEROSPACE • MITSUBISHI HEAVY • JOHN DEERE AUTOMOTIVE INDUSTRIES • • BELL HELICOPTER • MAUI PINEAPPLE CONTINENTAL • NASA COMPANY AUTOMOTIVE SYSTEMS • BOMBARDIER • • NGC INTEGRATED • USDA COOPER-STANDARD • CAE SYSTEMS AUTOMOTIVE Automotive • • CORNING • CESSNA AIRCRAFT NORTHROP GRUMMAN • AGCO • COMPANY • PRECISION CASTPARTS COSMA INDUSTRIAL DO • COBHAM CORP. • ALLIED SPECIALTY BRASIL • VEHICLES • CRP INDUSTRIES • COMAC RAYTHEON • AMSTED INDUSTRIES • • CUMMINS • DANAHER RAYTHEON E-SYSTEMS • ANHUI JIANGHUAI • • DAF TRUCKS • DASSAULT AVIATION RAYTHEON MISSLE AUTOMOBILE SYSTEMS COMPANY • • ARVINMERITOR DAIHATSU MOTOR • EATON • RAYTHEON NCS • • ASHOK LEYLAND DAIMLER • EMBRAER • RAYTHEON RMS • • ATC LOGISTICS & DALPHI METAL ESPANA • EUROPEAN AERONAUTIC • ROLLS-ROYCE DEFENCE AND SPACE ELECTRONICS • DANA HOLDING COMPANY • ROTORCRAFT • AUDI CORPORATION • FINMECCANICA ENTERPRISES • • AUTOZONE DANA INDÚSTRIAS • SAAB • FLIR SYSTEMS • • BAE SYSTEMS DELPHI • SMITH'S DETECTION • FUJI • • BECK/ARNLEY DENSO CORPORATION -
Nilotinib in Patients with Chronic Myeloid Leukemia: STAT2 Trial in Japan
Haematologica HAEMATOL/2018/194894 Version 3 Haematologica HAEMATOL/2018/194894 Version 3 Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in Japan Naoto Takahashi, Kaichi Nishiwaki, Chiaki Nakaseko, Nobuyuki Aotsuka, Koji Sano, Chikako Ohwada, Jun Kuroki, Hideo Kimura, Michihide Tokuhira, Kinuko Mitani, Kazuhisa Fujikawa, Osamu Iwase, Kohshi Ohishi, Fumihiko Kimura, Tetsuya Fukuda, Sakae Tanosaki, Saori Takahashi, Yoshihiro Kameoka, Hiroyoshi Nishikawa, and Hisashi Wakita Disclosures: 1. This study was supported by research funding from Novartis Pharmaceuticals to N.T. 2. N.T reports grants from Novartis Pharmaceuticals, during the conduct of the study; grants and personal fees from Novartis Pharmaceuticals, grants and personal fees from Otsuka, grants and personal fees from Pfizer, personal fees from Bristol-Myers Squibb, outside the submitted work; K.N reports grants from Zenyaku Kogyo Company, Limited, grants from Chugai Pharmaceutical, grants from Novartis Pharma K.K., grants from Kyowa Hakko Kirin Co, Ltd, grants from Nippon Shinyaku Co, Ltd, outside the submitted work; C.N reports personal fees from Novartis, grants and personal fees from Bristol-Myers Squibb, grants and personal fees from Pfizer, grants and personal fees from Takeda pharmaceuticals, grants and personal fees from Kyowa Hakko Kirin, grants and personal fees from Otsuka Pharmaceutical, grants and personal fees from Ono Pharmaceutical, grants and personal fees from Chugai Pharmaceutical, grants and personal fees from Asahi Kasei Pharma, grants and personal fees from Shionogi, personal fees from Shire, personal fees from Jannsen, personal fees from Celgene, outside the submitted work; M.T. reports personal fees from Bristol-Myers Squib, personal fees from Pfizer, outside the submitted work; K.M reports grants from Kyowa Hakko Kirin Co. -
OCTOBER 2020 PTAB Public Hearing Schedule
OCTOBER 2020 PTAB Public Hearing Schedule Proceeding No. Serial No. PARTY Date Time 2020-004197 16043641 BIOGEN MA INC Thursday, October 1, 2020 9:00 AM (EDT) ALLERGAN PHARMACEUTICALS 2020-002635 13907447 Thursday, October 1, 2020 9:00 AM (EDT) INTERNATIONAL LIMITED 2020-002276 13612925 BAYER AG (MONSANTO) Thursday, October 1, 2020 9:00 AM (EDT) 2020-002277 13612929 OTSUKA PHARMACEUTICAL CO., 2020-002304 14341306 Thursday, October 1, 2020 9:00 AM (EDT) LTD. 2020-002327 15893354 CELLECTIS Thursday, October 1, 2020 9:00 AM (EDT) 2020-000258 15163285 POLY GROUP LLC Thursday, October 1, 2020 9:00 AM (PDT) 2020-000640 15414456 DISCERNDX INC. Thursday, October 1, 2020 9:00 AM (PDT) 2020-000934 13982470 DENOVO BIOMARKERS INC. Thursday, October 1, 2020 9:00 AM (PDT) THE BOARD OF TRUSTEES OF THE 2020-001247 15175848 LELAND STANFORD JUNIOR Thursday, October 1, 2020 9:00 AM (PDT) UNIVERSITY EDWARDS LIFESCIENCES 2020-001487 14563866 Thursday, October 1, 2020 9:00 AM (PDT) CORPORATION IKEDA FOOD RESEARCH COL LTD 2020-003630 16145178 Thursday, October 1, 2020 1:00 PM (EDT) and PHC CORPORATION 2020-002049 13310632 ADARE PHARMACEUTICALS INC. Thursday, October 1, 2020 1:00 PM (EDT) 2020-000053 13135898 OLEG ILLICH EPSHTEIN Thursday, October 1, 2020 1:00 PM (EDT) 2020-001829 15008646 MERZ PHARMA GMBH & CO. KGAA Thursday, October 1, 2020 1:00 PM (EDT) 2020-002360 15407037 IONIS PHARMACEUTICALS INC. Thursday, October 1, 2020 1:00 PM (EDT) 2020-002113 13729631 L'OREAL Thursday, October 1, 2020 1:00 PM (EDT) 2019-003658 13576565 QUNZHU LI and LI LI Thursday, October 1, 2020 1:00 PM (EDT) 2020-000322 14136660 CYTEC INDUSTRIES INC. -
Corporate Social Responsibility Report 2016 Walgreens Boots Alliance Is the First Global Pharmacy-Led, Health and Wellbeing Enterprise
Corporate Social Responsibility Report 2016 Walgreens Boots Alliance is the first global pharmacy-led, health and wellbeing enterprise. Our purpose is to help people across the world lead healthier and happier lives. Our 2016 Corporate Social Responsibility Report covers the fiscal year that ended 31 August 2016. In this year’s report: Overview Marketplace Introduction ...................................................1 Our CSR goals .............................................2 28 Our vision, purpose and values ................3 Our approach to CSR .................................4 Contributing to the United Nations Sustainable Development Goals .............6 Transparency ........................................... 30 Our impact ...................................................8 Ethical Sourcing ...................................... 30 ........................... About our Company ................................. 10 External Stakeholders 31 Stakeholder engagement ....................... 12 Workplace Community 32 14 Employee Health and Wellbeing ........ 34 Equal Opportunities .............................. 36 Health and Wellbeing ............................. 16 Health and Safety ...................................37 Young People ........................................... 17 ...................................... Cancer Programs .....................................20 About this report 38 Data management process ................ 38 Environment Data ............................................................ 38 Community data -
CHINA FIELD TRIP May 10Th –12Th, 2011
CHINA FIELD TRIP May 10th –12th, 2011 This presentation may contain forward-looking statements. Such forward-looking statements do not constitute forecasts regarding the Company’s results or any other performance indicator, but rather trends or targets, as the case may be. These statements are by their nature subject to risks and uncertainties as described in the Company’s annual report available on its Internet website (www.psa-peugeot-citroen.com). These statements do not reflect future performance of the Company, which may materially differ. The Company does not undertake to provide updates of these statements. More comprehensive information about PSA PEUGEOT CITROËN may be obtained on its Internet website (www.psa-peugeot-citroen.com), under Regulated Information. th th China Field Trip - May 10 –12 , 2011 2 PSA in Asia – Market Forecast, PSA in China: ongoing successes and upsides Frédéric Saint-Geours Executive VP, Finance and Strategic Development Grégoire Olivier, Executive VP, Asia Table of contents Introduction China: the new auto superpower China: a global economic power The world’s largest automotive market The growth story is set to continue PSA in China China: a second home market for PSA 2 complementary JVs Key challenges in China and PSA differentiation factors A sustainable profitable growth Extending the Chinese Success ASEAN strategy Capturing the Indian opportunity th th China Field Trip - May 10 –12 , 2011 4 PSA – a global automotive player (1/2) > 39% of PSA’s 2010 sales are realized outside of Europe, of -
Daimler Annual Report 2014
Annual Report 2014. Key Figures. Daimler Group 2014 2013 2012 14/13 Amounts in millions of euros % change Revenue 129,872 117,982 114,297 +10 1 Western Europe 43,722 41,123 39,377 +6 thereof Germany 20,449 20,227 19,722 +1 NAFTA 38,025 32,925 31,914 +15 thereof United States 33,310 28,597 27,233 +16 Asia 29,446 24,481 25,126 +20 thereof China 13,294 10,705 10,782 +24 Other markets 18,679 19,453 17,880 -4 Investment in property, plant and equipment 4,844 4,975 4,827 -3 Research and development expenditure 2 5,680 5,489 5,644 +3 thereof capitalized 1,148 1,284 1,465 -11 Free cash flow of the industrial business 5,479 4,842 1,452 +13 EBIT 3 10,752 10,815 8,820 -1 Value added 3 4,416 5,921 4,300 -25 Net profit 3 7,290 8,720 6,830 -16 Earnings per share (in €) 3 6.51 6.40 6.02 +2 Total dividend 2,621 2,407 2,349 +9 Dividend per share (in €) 2.45 2.25 2.20 +9 Employees (December 31) 279,972 274,616 275,087 +2 1 Adjusted for the effects of currency translation, revenue increased by 12%. 2 For the year 2013, the figures have been adjusted due to reclassifications within functional costs. 3 For the year 2012, the figures have been adjusted, primarily for effects arising from application of the amended version of IAS 19. Cover photo: Mercedes-Benz Future Truck 2025. -
ANNUAL REPORT 2016 Corporate Philosophy
ANNUAL Otsuka Holdings Co., Ltd. ANNUAL REPORT 2016 REPORT 2016 For the year ended December 31, 2016 Corporate Philosophy Creating innovative products These words embody our commitment to: Contributing Improving to the human health lives of people worldwide In keeping with this corporate philosophy and the Otsuka mottos of Jissho (Actualization) and Sozosei (Creativity), the Otsuka Group strives to utilize its unique resources and skills to develop differentiated scientific solutions which contribute to the lives of people worldwide in the form of innovative and creative products ranging from pharmaceuticals to consumer products. We are striving to cultivate a culture and a dynamic corporate climate reflecting our vision as a healthcare company. Consistent with this approach, we are dedicated to achieving global sustainability, to our relationships with local communities, and to the protection of the natural environment. Contents About Otsuka Creating Corporate Value Corporate Philosophy Corporate Governance ............. 42 Directors, Audit & Supervisory Business Model ......................... 02 Board Members ........................ 48 Corporate Social Business Segments ................... 04 Responsibility ........................... 50 Financial and Non-Financial Finance & General Information Highlights ................................. 06 Financial Summary ................... 54 Consolidated Financial Statements ................ 56 Message from the President ..... 08 Group Structure & Overview of Main Operating Companies ..... -
84 Lumber Co-Manager Adelphoi Village, Inc. Jr. Accountant ALCOA Travel and Expense Processor Allegheny Energy Fuels Technician
Employer Position 84 Lumber Co-Manager Adelphoi Village, Inc. Jr. Accountant ALCOA Travel and Expense Processor Allegheny Energy Fuels Technician Accounting Allegheny Ludlum Staff Accountant I Allegheny Valley Bank of Pittsburgh Staff Accountant Asset Genie, Inc. Accounting Department Bechtel Plant Machinery Inc. Procurement Specialist I BDO USA Tax Accountant, Auditor, Litigation Support Bononi and Bononi Accountant Boy Scouts-Westmoreland Fayette Council Accounting Specialist/Bookkeeper City of Greensburg Fiscal Assistant A/R Coca-Cola Budget Analyst DeLallo’s Italian Store Manager Department of Veteran Affairs-Dayton VA Accountant Trainee Medical Center Dept. of the Navy - Naval Audit Service Auditor Diamond Drugs, Inc. Staff Accountant Enterprise Rent A Car Accounting Coordinator FedEx Services Auditor First Commonwealth Financial Corporation Management Trainee - 16 month management development program Fox and James Inc. Controller (Office MGR, HR MGR, Accountant, Auditor) General American Corp. Accounts Payable Assistant Giant Eagle Staff Accountant Highmark Accountant One Inspector General's Office, Department of Junior Auditor Defense Irwin Bank and Trust Company Management Trainee James L. Wintergreen CPA Office Manager/Accountant - payroll, taxes John Wall, Inc Accountant Jordan Tax Service Accounting Clerk Kennametal Inc. Business Analyst Kennametal, Inc. Internal Auditor Limited Brands Internal Auditor Maher Duessel, CPAs Staff Accountant Malin, Bergquist & Company, LLP Staff Accountant Marathon Ashland Petroleum LLC Audit Staff -
Electrolytic Capacitors (“Capacitors”) In
Court File No.: 3795/14 CP ONTARIO SUPERIOR COURT OF JUSTICE B E T W E E N: CYGNUS ELECTRONICS CORPORATION Plaintiff - and - PANASONIC CORPORATION; PANASONIC CORPORATION OF NORTH AMERICA; PANASONIC CANADA INC.; SANYO ELECTRIC CO., LTD.; SANYO NORTH AMERICA CORPORATION; TAIYO YUDEN CO., LTD.; TAIYO YUDEN (USA) INC.; TAIYO YUDEN (USA) INC. O/A TAIYO YUDEN CANADA; NEC TOKIN CORPORATION; NEC TOKIN AMERICA INC.; NEC CANADA INC.; KEMET CORPORATION; KEMET ELECTRONICS CORPORATION; NIPPON CHEMI-CON CORPORATION; UNITED CHEMI-CON CORPORATION; HITACHI CHEMICAL CO., LTD.; HITACHI CHEMICAL COMPANY AMERICA, LTD.; HITACHI CANADA; NICHICON CORPORATION; NICHICON (AMERICA) CORPORATION; AVX CORPORATION; RUBYCON CORPORATION; RUBYCON AMERICA INC.; ELNA CO., LTD.; ELNA AMERICA INC.; MATSUO ELECTRIC CO., LTD.; TOSHIN KOGYO CO., LTD.; VISHAY INTERTECHNOLOGY INC.; SAMSUNG ELECTRO- MECHANICS; SAMSUNG ELECTRO-MECHANICS AMERICA INC.; SAMSUNG ELECTRONICS CANADA INC.; ROHM CO., LTD.; ROHM SEMICONDUCTOR U.S.A., LLC. Defendants PROCEEDING UNDER THE CLASS PROCEEDINGS ACT, 1992 , S.O. 1992, c.6 PLAINTIFF’S MOTION RECORD (Motion for Discontinuances) November 18, 2016 HARRISON PENSA LLP Barristers & Solicitors 450 Talbot Street London, ON N6A 4K3 Jonathan J. Foreman (LSUC #45087H) Sarah A. Bowden (LSUC #56385D) Tel: (519) 679-9660 Fax: (519) 667-3362 E-mail: [email protected] [email protected] Lawyers for the Plaintiff TO: Miller Thomson LLP Scotia Plaza, 40 King St. W. Suite 5800 Toronto, ON M5H 3S1 Eric Dufour Pascale Cloutier Tel: (416) 595-8500 Fax: (416) 595-8695 E-mail: [email protected] and [email protected] Lawyers for the Defendant AVX Corporation AND TO: DLA Piper (Canada) LLP 1 First Canadian Place, Suite 6000 P.O. -
Local Businesses – Large and Small
Local Businesses – Large and Small The details of the local businesses documented below have been researched by the Local History Group. Thomas Glover & Son Thomas Glover & Son, elastic web and fabric manufacturers appeared in the Post Office Directory for Nottinghamshire in 1855. The company is recorded as having several addresses in Nottingham, however it had disappeared from the directory by 1900, returning in 1925 described as a surgical hosier in Chesterfield Street, Carlton. The firm remained at that address until the 1970s. The company’s buildings were on both sides of Chesterfield Street but are now demolished, new houses being built on the side. Turney Brothers In 1861 two brothers, Edward and John Turney built a tannery and began to make leather on a site next to the River Trent and the adjacent canal in Nottingham, known as Sneinton Island. The first buildings took up only a fraction of the space that by the 1920s had developed into a large site with labour-saving machinery imported from many countries. They traded under the name of Turney Brothers and had offices in London, Leicester and Manchester. Edward left some years after the commencement of the company and the driving force was John Turney who was in sole charge for over a quarter of a century. In 1888 the company re-organised into a Limited Company, John being chairman. John led an exceptionally distinguished social, political and commercial life. He was a member of Nottingham Corporation for 46 years, and became Sheriff and then Alderman in 1879 and Mayor for two years 1886 – 1888. -
Corporate Finance Guide 2021 CORPORATE FINANCE GUIDE SPECIAL | CORPORATE
01/06/2021 15:30 15:30 01/06/2021 01/06/2021 1 1 cover.indd cover.indd Guide Guide Finance Finance Corporate Corporate MIDLANDS BUSINESS INSIDER www.midlandsbusinessinsider.com JULY 2021 JULY midlands businessinsider WEST ™ MIDLANDS insiderEDITION VOL.29 NO.7 £10 JULY 2021 West Midlands Mayor What does business want from Andy Street’s second term? CITY OF CULTURE CITY OFCULTURE Wolverhampton The new home of green construction | SMEGUIDE Mental health | MENTAL HEALTH HEALTH MENTAL Helping a colleague on the edge | RESIDENTIAL AWARDS RESIDENTIALAWARDS | CORPORATE FINANCEGUIDESPECIAL CORPORATE Guide Guide 2021 Corporate Finance Corporate MIDLANDS | CIRCULARECONOMY FIREDHOW A YEAR AS CITY OF CULTURE UP! IS VOL.29 N VOL.29 SPARKING GROWTH IN COVENTRY O 7 MBI July 2021 cover MASTER.indd 1 02/06/2021 15:00 Optimising outcomes for our clients no matter what their destination DLA Piper has been the No 1 M&A law firm, both in the UK and globally, for each of the past 11 years. Trusted adviser to: Put simply, we do things that other law firms cannot. Times 2 SISTERS FOOD GROUP may change, but our qualities do not. Our clients trust us with Advised on the GBP246m sale of part of Fox’s Biscuits to their most important, strategic and transformational M&A and Ferrero Group. ECM transactions. We use our market and sector intelligence and unrivalled deal execution experience to drive and obtain NOBLE GROUP optimal outcomes for our clients, no matter what the deal type, Advised on the sale of chilled dessert brand Gü to Exponent the transaction process, the geography or the counter-party.